This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Korea Research Institute of Chemical Technology. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Heung Kyoung Lee: Innovator in Pharmaceutical Chemistry
Introduction
Heung Kyoung Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target autoimmune diseases and tumors.
Latest Patents
Heung Kyoung Lee holds a patent for a tricyclic compound as an IRAK4 inhibitor. This invention relates to a pharmaceutical composition designed to prevent or treat autoimmune diseases or tumors. The active ingredient in this composition is a tricyclic compound, which is represented by a specific chemical formula or a pharmaceutically acceptable salt thereof. This innovation also includes a health food composition aimed at alleviating these medical conditions.
Career Highlights
Heung Kyoung Lee is affiliated with the Korea Research Institute of Chemical Technology. His work focuses on the intersection of chemistry and medicine, where he seeks to develop effective treatments for complex health issues.
Collaborations
Heung Kyoung Lee has collaborated with notable colleagues, including Heeyeong Cho and Hee-Jong Lim. These partnerships enhance the research and development efforts in their respective fields.
Conclusion
Heung Kyoung Lee's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his role as a key inventor in the fight against autoimmune diseases and tumors. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile